XSTOLINC
Market cap445mUSD
Dec 23, Last price
85.30SEK
1D
0.47%
1Q
-0.93%
IPO
-19.07%
Name
Linc AB
Chart & Performance
P/E
7.97
P/S
1,353.36
EPS
10.70
Div Yield, %
0.00%
Shrs. gr., 5y
-1.17%
Rev. gr., 5y
-8.64%
Revenues
4m
+53.94%
Net income
619m
P
CFO
-81m
L-64.69%
Earnings
May 15, 2025
Profile
Linc AB is a private equity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.private eequity and venture capital firm, specializing in early, mid and late venture investments in pharmaceutical, life-science and med-tech companies, respectively. The firm prefers to invest in Nordic companies. It usually invests from SEK 25 million to SEK 250 million, the first investment often being a relatively small one and the follow-up investments comprising the larger part of the investment. Linc AB is based in Stockholm, Sweden.
Valuation
Title SEK in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|
| 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | |
| Income | ||||||
Revenues | 3,650 53.94% | 2,371 -42.70% | 4,138 215.64% | |||
Cost of revenue | 2,746 | 5,034 | 17,327 | |||
Unusual Expense (Income) | ||||||
NOPBT | 904 | (2,663) | (13,189) | |||
NOPBT Margin | 24.77% | |||||
Operating Taxes | 46,641 | (172,576) | (8,072) | |||
Tax Rate | 5,159.40% | |||||
NOPAT | (45,737) | 169,913 | (5,117) | |||
Net income | 619,459 -185.64% | (723,335) 2,308.79% | (30,029) -103.60% | |||
Dividends | ||||||
Dividend yield | ||||||
Proceeds from repurchase of equity | 1,200,000 | |||||
BB yield | -23.92% | |||||
| Debt | ||||||
Debt current | ||||||
Long-term debt | 717,156 | |||||
Deferred revenue | 2,847 | 130,479 | ||||
Other long-term liabilities | 1,000 | (2,700) | (847,635) | |||
Net debt | (3,467,820) | (2,822,048) | (3,026,929) | |||
| Cash flow | ||||||
Cash from operating activities | (80,569) | (228,147) | (353,839) | |||
CAPEX | ||||||
Cash from investing activities | (199,751) | (339,448) | ||||
Cash from financing activities | (5,000) | 1,160,625 | ||||
FCF | (121,671) | 219,514 | (2,019) | |||
| Balance | ||||||
Cash | 519,978 | 600,547 | 828,693 | |||
Long term investments | 2,947,842 | 2,221,501 | 2,915,392 | |||
Excess cash | 3,467,637 | 2,821,929 | 3,743,878 | |||
Stockholders' equity | 2,362,110 | 5,788,560 | 7,730,422 | |||
Invested Capital | 1,166,946 | 87,612 | (111,005) | |||
ROIC | 4.23% | |||||
ROCE | 0.03% | |||||
| EV | ||||||
Common stock shares outstanding | 57,910 | 57,910 | 50,382 | |||
Price | 64.60 8.66% | 59.45 -40.29% | 99.56 | |||
Market cap | 3,741,015 8.66% | 3,442,776 -31.36% | 5,016,047 | |||
EV | 273,195 | 1,757,041 | 3,620,621 | |||
EBITDA | 904 | (2,663) | (13,189) | |||
EV/EBITDA | 302.21 | |||||
Interest | 2,515 | 1,174 | ||||
Interest/NOPBT | ||||||